ACS Medicinal Chemistry Letters · 2012 · 22 citations · 10 references
MedicineNuclear MedicineOncologyDiagnostic ImagingDiagnostic RadiologyMolecular ImagingMagnetic Resonance Contrast MechanismsMagnetic Resonance ImagingNuclear Medicine ChemistryTargeted Imaging AgentsTargeting LigandsTumor ImagingContrast Agent DesignMagnetic Resonance Imaging Contrast AgentsMolecular Imaging Probe DesignMolecular Targeting LigandsRadioligand ImagingRadiotracers Targeting IntegrinsSensitivityTargeted Molecular Imaging Agents
The work describes the synthesis and in vivo application of [Gd(L)(H2O)]·xH2O, where L is a ((125)I/(127)I-RGD)- DOTA conjugate, as a tumor-targeting SPECT/MR bimodal imaging probe. Here, ((125)I/(127)I-RGD)-DOTA signifies a "cocktail mixture" of radioisotopic (1a, L = (125)I-RGD-DOTA) and natural (1b, L = (127)I-RGD-DOTA) Gd complexes. The two complexes are chemically equivalent as revealed by HPLC, and their cocktail mixture exhibits the integrin-specific tumor enhancement, demonstrating that they constitute essentially a single bimodal imaging probe. Employment of a cocktail mixture thus proves to be a sole and practical approach to overcome the sensitivity difference problem between MRI and SPECT.
10
Roland Haubner, Rainer Gratias, Beate Diefenbach et al. · Journal of the American Chemical Society · 1996 · 580 citations
Sodium iodide symporter: its role in nuclear medicine.
June-Key Chung · PubMed · 2002 · 318 citations
Bimodal MR–PET Agent for Quantitative pH Imaging
Luca Frullano, Ciprian Catana, Thomas Benner et al. · Angewandte Chemie International Edition · 2010 · 169 citations · Full text
Thomas L. Mindt, Cristina Müller, Marleen Melis et al. · Bioconjugate Chemistry · 2008 · 101 citations
Gd‐DOTA Conjugate of RGD as a Potential Tumor‐Targeting MRI Contrast Agent
Ji Ae Park, Jae‐Jun Lee, Jae‐Chang Jung et al. · ChemBioChem · 2008 · 69 citations